{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:22:22Z","timestamp":1791685342718,"version":"4.3.4"},"reference-count":121,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"statutory budget of the Department of Biochemistry and Medical Chemistry at Pomeranian Medical University in Szczecin, Poland"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Acute myeloid leukemia (AML) is a type of leukemia known for its unfavorable prognoses, prompting research efforts to discover new therapeutic targets. One area of investigation involves examining extracellular factors, particularly CXC chemokines. While CXCL12 (SDF-1) and its receptor CXCR4 have been extensively studied, research on other CXC chemokine axes in AML is less developed. This study aims to bridge that gap by providing an overview of the significance of CXC chemokines other than CXCL12 (CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 ligands and CXCL14 and CXCL17) in AML\u2019s oncogenic processes. We explore the roles of all CXC chemokines other than CXCL12, in particular CXCL1 (Gro-\u03b1), CXCL8 (IL-8), CXCL10 (IP-10), and CXCL11 (I-TAC) in AML tumor processes, including their impact on AML cell proliferation, bone marrow angiogenesis, interaction with non-leukemic cells like MSCs and osteoblasts, and their clinical relevance. We delve into how they influence prognosis, association with extramedullary AML, induction of chemoresistance, effects on bone marrow microvessel density, and their connection to French\u2013American\u2013British (FAB) classification and FLT3 gene mutations.<\/jats:p>","DOI":"10.3390\/cancers15184555","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T10:00:23Z","timestamp":1694685623000},"page":"4555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML)"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1642-1259","authenticated-orcid":false,"given":"Jan","family":"Korbecki","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta\u0144c\u00f3w Wlkp. 72, 70-111 Szczecin, Poland"},{"name":"Department of Anatomy and Histology, Collegium Medicum, University of Zielona G\u00f3ra, Zyty 28, 65-046 Zielona G\u00f3ra, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0756-6483","authenticated-orcid":false,"given":"Patrycja","family":"Kupnicka","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta\u0144c\u00f3w Wlkp. 72, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6381-566X","authenticated-orcid":false,"given":"Katarzyna","family":"Barczak","sequence":"additional","affiliation":[{"name":"Department of Conservative Dentistry and Endodontics, Pomeranian Medical University in Szczecin, Powsta\u0144c\u00f3w Wlkp. 72, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Bosiacki","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta\u0144c\u00f3w Wlkp. 72, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Zi\u0119tek","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Traumatology and Orthopaedic Oncology, Pomeranian Medical University, Unii Lubelskiej 1, 71-252 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4497-4395","authenticated-orcid":false,"given":"Dariusz","family":"Chlubek","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta\u0144c\u00f3w Wlkp. 72, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9187-8895","authenticated-orcid":false,"given":"Irena","family":"Baranowska-Bosiacka","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta\u0144c\u00f3w Wlkp. 72, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12032-018-1179-3","article-title":"Overall Survival of Brazilian Acute Myeloid Leukemia Patients According to the European LeukemiaNet Prognostic Scoring System: A Cross-Sectional Study","volume":"35","author":"Datoguia","year":"2018","journal-title":"Med. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jgo.2020.11.001","article-title":"Clinical Outcome of Older Adults with Acute Myeloid Leukemia: An Analysis of a Large Tertiary Referral Center over Two Decades","volume":"12","author":"Ihlow","year":"2021","journal-title":"J. Geriatr. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"24001","DOI":"10.1038\/s41598-021-03559-3","article-title":"First Report from a Single Center Retrospective Study in Kazakhstan on Acute Myeloid Leukemia Treatment Outcomes","volume":"11","author":"Kulkayeva","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_5","first-page":"16344","article-title":"Clinical Outcomes of Therapy-Related Acute Myeloid Leukemia: An over 20-Year Single-Center Retrospective Analysis","volume":"133","author":"Adamska","year":"2023","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-020-00908-z","article-title":"The Global Burden and Attributable Risk Factor Analysis of Acute Myeloid Leukemia in 195 Countries and Territories from 1990 to 2017: Estimates Based on the Global Burden of Disease Study 2017","volume":"13","author":"Yi","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A Guide to Chemokines and Their Receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A Web Server for Cancer and Normal Gene Expression Profiling and Interactive Analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: An Update to the Integrated Cancer Data Analysis Platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2011-10-383406","article-title":"A Phase 1\/2 Study of Chemosensitization with the CXCR4 Antagonist Plerixafor in Relapsed or Refractory Acute Myeloid Leukemia","volume":"119","author":"Uy","year":"2012","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/1078-0432.CCR-12-2333","article-title":"BMS-936564\/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis in Vitro and Shows Antitumor Activity in Vivo in Hematologic Malignancies","volume":"19","author":"Kuhne","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e26414","DOI":"10.1002\/pbc.26414","article-title":"A Phase 1 Study of the CXCR4 Antagonist Plerixafor in Combination with High-Dose Cytarabine and Etoposide in Children with Relapsed or Refractory Acute Leukemias or Myelodysplastic Syndrome: A Pediatric Oncology Experimental Therapeutics Investigators\u2019 Consortium Study (POE 10-03)","volume":"64","author":"Cooper","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: A New Classification System and Their Role in Immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj2750581","article-title":"Formation of Neutrophil-Activating Peptide 2 from Platelet-Derived Connective-Tissue-Activating Peptide III by Different Tissue Proteinases","volume":"275","author":"Car","year":"1991","journal-title":"Biochem. J."},{"key":"ref_16","first-page":"L249","article-title":"Generation of the Neutrophil-Activating Peptide-2 by Cathepsin G and Cathepsin G-Treated Human Platelets","volume":"263","author":"Cohen","year":"1992","journal-title":"Am. J. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF Is a Noncognate Ligand of CXC Chemokine Receptors in Inflammatory and Atherogenic Cell Recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1039\/C4CP05095A","article-title":"Exploring the Binding Mechanisms of MIF to CXCR2 Using Theoretical Approaches","volume":"17","author":"Xu","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1432-1327.1998.2550067.x","article-title":"Differential Usage of the CXC Chemokine Receptors 1 and 2 by Interleukin-8, Granulocyte Chemotactic Protein-2 and Epithelial-Cell-Derived Neutrophil Attractant-78","volume":"255","author":"Wuyts","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20545","DOI":"10.1074\/jbc.271.34.20545","article-title":"The CXC Chemokines Growth-Regulated Oncogene (GRO) Alpha, GRObeta, GROgamma, Neutrophil-Activating Peptide-2, and Epithelial Cell-Derived Neutrophil-Activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor","volume":"271","author":"Ahuja","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-5793(94)80454-0","article-title":"Both Interleukin-8 Receptors Independently Mediate Chemotaxis. Jurkat Cells Transfected with IL-8R1 or IL-8R2 Migrate in Response to IL-8, GRO Alpha and NAP-2","volume":"341","author":"Loetscher","year":"1994","journal-title":"FEBS Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/bj2820429","article-title":"G-Protein Activation by Interleukin 8 and Related Cytokines in Human Neutrophil Plasma Membranes","volume":"282","author":"Kupper","year":"1992","journal-title":"Biochem. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1073\/pnas.89.21.10542","article-title":"High- and Low-Affinity Binding of GRO Alpha and Neutrophil-Activating Peptide 2 to Interleukin 8 Receptors on Human Neutrophils","volume":"89","author":"Schumacher","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.171.5.1797","article-title":"Neutrophil-Activating Properties of the Melanoma Growth-Stimulatory Activity","volume":"171","author":"Moser","year":"1990","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41590-022-01200-7","article-title":"Single-Cell Analysis Identifies the Interaction of Altered Renal Tubules with Basophils Orchestrating Kidney Fibrosis","volume":"23","author":"Doke","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"27348","DOI":"10.1074\/jbc.270.45.27348","article-title":"The Functional Role of the ELR Motif in CXC Chemokine-Mediated Angiogenesis","volume":"270","author":"Strieter","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.4049\/jimmunol.165.9.5269","article-title":"The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity","volume":"165","author":"Addison","year":"2000","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12964-021-00775-2","article-title":"Aiduqing Formula Inhibits Breast Cancer Metastasis by Suppressing TAM\/CXCL1-Induced Treg Differentiation and Infiltration","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s43018-021-00227-3","article-title":"Castration-Mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression","volume":"2","author":"Haffner","year":"2021","journal-title":"Nat. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.31557\/APJCP.2021.22.10.3377","article-title":"CXCL1, CXCL10 and CXCL12 Chemokines Are Variously Expressed in Acute Myeloid Leukemia Patients Prior and Post Bone Marrow Transplantation","volume":"22","author":"Yazdani","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood.V87.9.4016.bloodjournal8794016","article-title":"Serum Interleukin-8 (IL-8) and IL-6 Concentrations in Patients with Hematologic Malignancies","volume":"87","author":"Denizot","year":"1996","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2010-01-262071","article-title":"Recurrent Expression Signatures of Cytokines and Chemokines Are Present and Are Independently Prognostic in Acute Myelogenous Leukemia and Myelodysplasia","volume":"116","author":"Kornblau","year":"2010","journal-title":"Blood"},{"key":"ref_33","first-page":"50","article-title":"Biochip Array Technology and Evaluation of Serum Levels of Multiple Cytokines and Adhesion Molecules in Patients with Newly Diagnosed Acute Myeloid Leukemia","volume":"36","author":"Horacek","year":"2014","journal-title":"Exp. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bbrc.2018.03.181","article-title":"CXCL8 Is Associated with the Recurrence of Patients with Acute Myeloid Leukemia and Cell Proliferation in Leukemia Cell Lines","volume":"499","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/bjc.2017.316","article-title":"Circulating Cytokines and Small Molecules Follow Distinct Expression Patterns in Acute Myeloid Leukaemia","volume":"117","author":"Islam","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cyto.2012.12.023","article-title":"Cytokine Profiles in Acute Myeloid Leukemia Patients at Diagnosis: Survival Is Inversely Correlated with IL-6 and Directly Correlated with IL-10 Levels","volume":"61","author":"Bergua","year":"2013","journal-title":"Cytokine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"106180","DOI":"10.1016\/j.leukres.2019.106180","article-title":"Interleukin-8 Blockade Prevents Activated Endothelial Cell Mediated Proliferation and Chemoresistance of Acute Myeloid Leukemia","volume":"84","author":"Vijay","year":"2019","journal-title":"Leuk. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clml.2014.10.003","article-title":"Overexpression of GYS1, MIF, and MYC Is Associated with Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia","volume":"15","author":"Falantes","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/bloodadvances.2019001124","article-title":"Highly Multiplexed Proteomic Assessment of Human Bone Marrow in Acute Myeloid Leukemia","volume":"4","author":"Lindblad","year":"2020","journal-title":"Blood Adv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3324\/haematol.10148","article-title":"Subclassification of Patients with Acute Myelogenous Leukemia Based on Chemokine Responsiveness and Constitutive Chemokine Release by Their Leukemic Cells","volume":"92","author":"Bruserud","year":"2007","journal-title":"Haematologica"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.scr.2015.09.008","article-title":"The Cytokine-Mediated Crosstalk between Primary Human Acute Myeloid Cells and Mesenchymal Stem Cells Alters the Local Cytokine Network and the Global Gene Expression Profile of the Mesenchymal Cells","volume":"15","author":"Reikvam","year":"2015","journal-title":"Stem. Cell Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1182\/blood-2015-01-621631","article-title":"IL8-CXCR2 Pathway Inhibition as a Therapeutic Strategy against MDS and AML Stem Cells","volume":"125","author":"Schinke","year":"2015","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1182\/blood-2008-02-134411","article-title":"An 86-Probe-Set Gene-Expression Signature Predicts Survival in Cytogenetically Normal Acute Myeloid Leukemia","volume":"112","author":"Metzeler","year":"2008","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.celrep.2016.07.058","article-title":"GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells","volume":"16","author":"Katsumura","year":"2016","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2141.2001.02722.x","article-title":"Increased Bone Marrow Vascularization in Patients with Acute Myeloid Leukaemia: A Possible Role for Vascular Endothelial Growth Factor","volume":"113","author":"Rosati","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1182\/blood.V82.8.2517.2517","article-title":"Constitutive Expression of Interleukin-8 and Its Receptor in Human Myeloid and Lymphoid Leukemia","volume":"82","author":"Tobler","year":"1993","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"18411","DOI":"10.1038\/srep18411","article-title":"IL-8 as Mediator in the Microenvironment-Leukaemia Network in Acute Myeloid Leukaemia","volume":"5","author":"Kuett","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_48","first-page":"1552","article-title":"IL-8 MRNA Expression and IL-8 Production by Acute Myeloid Leukemia Cells","volume":"7","author":"Vinante","year":"1993","journal-title":"Leukemia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0301-472X(03)00066-3","article-title":"The Characterization of Chemokine Production and Chemokine Receptor Expression Reveals Possible Functional Cross-Talks in AML Blasts with Monocytic Differentiation","volume":"31","author":"Cignetti","year":"2003","journal-title":"Exp. Hematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.exphem.2007.07.015","article-title":"MOZ and MOZ-CBP Cooperate with NF-KappaB to Activate Transcription from NF-KappaB-Dependent Promoters","volume":"35","author":"Chan","year":"2007","journal-title":"Exp. Hematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"584766","DOI":"10.3389\/fonc.2020.584766","article-title":"Risk Stratification in Acute Myeloid Leukemia Using CXCR Gene Signatures: A Bioinformatics Analysis","volume":"10","author":"Lu","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2040620720958586","DOI":"10.1177\/2040620720958586","article-title":"High CXCR2 Expression Predicts Poor Prognosis in Adult Patients with Acute Myeloid Leukemia","volume":"11","author":"Tang","year":"2020","journal-title":"Ther. Adv. Hematol."},{"key":"ref_53","first-page":"331","article-title":"Analysis of Unfavorable Prognosis Gene Markers in Patients with Acute Myeloid Leukemia by Multiomics","volume":"27","author":"Chen","year":"2019","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e23052","DOI":"10.1002\/jcla.23052","article-title":"A-Kinase Interacting Protein 1 Might Serve as a Novel Biomarker for Worse Prognosis through the Interaction of Chemokine (C-X-C Motif) Ligand 1\/Chemokine (C-X-C Motif) Ligand 2 in Acute Myeloid Leukemia","volume":"34","author":"Hao","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional Genomic Landscape of Acute Myeloid Leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/ijlh.13512","article-title":"CXCL2 Benefits Acute Myeloid Leukemia Cells in Hypoxia","volume":"43","author":"Li","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"723001","DOI":"10.3389\/fgene.2021.723001","article-title":"Identification of Potential Novel Prognosis-Related Genes Through Transcriptome Sequencing, Bioinformatics Analysis, and Clinical Validation in Acute Myeloid Leukemia","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/08820139.2019.1661429","article-title":"Serum Chemokine-Release Profiles in AML-Patients Might Contribute to Predict the Clinical Course of the Disease","volume":"49","author":"Merle","year":"2020","journal-title":"Immunol. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1096\/fj.201801931R","article-title":"CXCL8 Derived from Mesenchymal Stromal Cells Supports Survival and Proliferation of Acute Myeloid Leukemia Cells through the PI3K\/AKT Pathway","volume":"33","author":"Cheng","year":"2019","journal-title":"FASEB J."},{"key":"ref_60","first-page":"154","article-title":"Hypoxia Increases HIF-1\u03b1 Expression and Constitutive Cytokine Release by Primary Human Acute Myeloid Leukaemia Cells","volume":"21","author":"Hatfield","year":"2010","journal-title":"Eur. Cytokine Netw."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1038\/s41388-018-0151-1","article-title":"HIF1\u03b1 Drives Chemokine Factor Pro-Tumoral Signaling Pathways in Acute Myeloid Leukemia","volume":"37","author":"Shafat","year":"2018","journal-title":"Oncogene"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"32428","DOI":"10.1038\/srep32428","article-title":"The Oncometabolite R-2-Hydroxyglutarate Activates NF-\u039aB-Dependent Tumor-Promoting Stromal Niche for Acute Myeloid Leukemia Cells","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fimmu.2017.00106","article-title":"Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular Mechanisms","volume":"8","author":"Brenner","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_64","first-page":"19","article-title":"The Angiogenic Chemokines Expression Profile of Myeloid Cell Lines Co-Cultured with Bone Marrow-Derived Mesenchymal Stem Cells","volume":"20","author":"Shamsasenjan","year":"2018","journal-title":"Cell J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/0008-5472.CAN-16-1095","article-title":"MIF-Induced Stromal PKC\u03b2\/IL8 Is Essential in Human Acute Myeloid Leukemia","volume":"77","author":"Shafat","year":"2017","journal-title":"Cancer Res."},{"key":"ref_66","first-page":"391","article-title":"Osteoblasts Increase Proliferation and Release of Pro-Angiogenic Interleukin 8 by Native Human Acute Myelogenous Leukemia Blasts","volume":"89","author":"Bruserud","year":"2004","journal-title":"Haematologica"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lfs.2019.02.003","article-title":"Leukemia-Derived Exosomes Induced IL-8 Production in Bone Marrow Stromal Cells to Protect the Leukemia Cells against Chemotherapy","volume":"221","author":"Chen","year":"2019","journal-title":"Life Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood.V95.8.2637","article-title":"Increased Angiogenesis in the Bone Marrow of Patients with Acute Myeloid Leukemia","volume":"95","author":"Ruiz","year":"2000","journal-title":"Blood"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/mpo.1244","article-title":"A Possible Role for Spontaneous Interleukin-8 Production by Acute Myeloid Leukemic Cells in Angiogenesis Related Processes: Work in Progress","volume":"37","author":"Vellenga","year":"2001","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/ejh.12016","article-title":"Soluble Mediators Released by Acute Myeloid Leukemia Cells Increase Capillary-like Networks","volume":"89","author":"Hatfield","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/carcin\/bgs386","article-title":"Cross-Talk between Leukemic and Endothelial Cells Promotes Angiogenesis by VEGF Activation of the Notch\/Dll4 Pathway","volume":"34","author":"Zhang","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2141.2008.07411.x","article-title":"Primary Human Acute Myeloid Leukaemia Cells Increase the Proliferation of Microvascular Endothelial Cells through the Release of Soluble Mediators","volume":"144","author":"Hatfield","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular Profiling and Clinical Implications of Patients with Acute Myeloid Leukemia and Extramedullary Manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the Human Tissue-Specific Expression by Genome-Wide Integration of Transcriptomics and Antibody-Based Proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol. Cell Proteom."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1515\/hsz-2020-0196","article-title":"HDAC8 Promotes Daunorubicin Resistance of Human Acute Myeloid Leukemia Cells via Regulation of IL-6 and IL-8","volume":"402","author":"Wu","year":"2021","journal-title":"Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Cao, H., Tadros, V., Hiramoto, B., Leeper, K., Hino, C., Xiao, J., Pham, B., Kim, D.H., Reeves, M.E., and Chen, C.-S. (2022). Targeting TKI-Activated NFKB2-MIF\/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability. Biomedicines, 10.","DOI":"10.3390\/biomedicines10051038"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.bcp.2013.04.011","article-title":"Molecular Mechanisms of the Antitumor Activity of SB225002: A Novel Microtubule Inhibitor","volume":"85","author":"Goda","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/mol.116.105502","article-title":"CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways","volume":"90","author":"Berchiche","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4","volume":"197","author":"Lasagni","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI1422","article-title":"The Chemokine Receptors CXCR3 and CCR5 Mark Subsets of T Cells Associated with Certain Inflammatory Reactions","volume":"101","author":"Qin","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00262-005-0080-z","article-title":"T Lymphocyte Chemotactic Chemokines in Acute Myelogenous Leukemia (AML): Local Release by Native Human AML Blasts and Systemic Levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC)","volume":"55","author":"Olsnes","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"895","DOI":"10.4049\/jimmunol.159.2.895","article-title":"Suppressive Effects of Recombinant Human Monokine Induced by IFN-Gamma (RHuMig) Chemokine on the Number of Committed and Primitive Hemopoietic Progenitors in Liquid Cultures of CD34+ Human Bone Marrow Cells","volume":"159","author":"Schwartz","year":"1997","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.15537\/smj.2019.11.24584","article-title":"Overall Survival of Adult Acute Myeloid Leukemia Based on Cytogenetic and Molecular Abnormalities during 5 Years in a Single Center Study","volume":"40","author":"Alsobhi","year":"2019","journal-title":"Saudi Med. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1080\/10428194.2018.1515938","article-title":"Clinical and Biological Characteristics of Acute Myeloid Leukemia with 20-29% Blasts: A Retrospective Single-Center Study","volume":"60","author":"Mei","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1038\/leu.2016.81","article-title":"Leukemia Cell Infiltration Causes Defective Erythropoiesis Partially through MIP-1\u03b1\/CCL3","volume":"30","author":"Wang","year":"2016","journal-title":"Leukemia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.18632\/aging.102477","article-title":"Identification of Prognostic Genes in the Acute Myeloid Leukemia Microenvironment","volume":"11","author":"Huang","year":"2019","journal-title":"Aging"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-0609.2001.0430a.x","article-title":"Platelet-Derived Growth Factor (PDGF) in Human Acute Myelogenous Leukemia: PDGF Receptor Expression, Endogenous PDGF Release and Responsiveness to Exogenous PDGF Isoforms by in Vitro Cultured Acute Myelogenous Leukemia Blasts","volume":"67","author":"Foss","year":"2001","journal-title":"Eur. J. Haematol."},{"key":"ref_88","first-page":"757","article-title":"Human Recombinant Interferon-Inducible Protein-10 Inhibits the Proliferation of Normal and Acute Myelogenous Leukemia Progenitors","volume":"10","author":"Sarris","year":"1996","journal-title":"Leukemia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1309\/AJCP34YERPZSCYKQ","article-title":"Discordant Immunophenotypic Profiles of Adhesion Molecules and Cytokines in Acute Myeloid Leukemia Involving Bone Marrow and Skin","volume":"138","author":"Sachdev","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.leukres.2012.11.013","article-title":"Correlation between Cytokine Levels and Changes in Fatigue and Quality of Life in Patients with Acute Myeloid Leukemia","volume":"37","author":"Fung","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B Cell-Attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/cyto.2001.0923","article-title":"Human B Cell-Attracting Chemokine 1 (BCA-1; CXCL13) Is an Agonist for the Human CXCR3 Receptor","volume":"15","author":"Jenh","year":"2001","journal-title":"Cytokine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1074-7613(01)00257-6","article-title":"CXCL13 Is Required for B1 Cell Homing, Natural Antibody Production, and Body Cavity Immunity","volume":"16","author":"Ansel","year":"2002","journal-title":"Immunity"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","article-title":"Follicular B Helper T Cells Express CXC Chemokine Receptor 5, Localize to B Cell Follicles, and Support Immunoglobulin Production","volume":"192","author":"Breitfeld","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41419-021-04136-2","article-title":"CXCL13\/CXCR5 Axis Facilitates Endothelial Progenitor Cell Homing and Angiogenesis during Rheumatoid Arthritis Progression","volume":"12","author":"Tsai","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/bbrc.2001.5924","article-title":"The Chemokine CXCL13 (BCA-1) Inhibits FGF-2 Effects on Endothelial Cells","volume":"289","author":"Spinetti","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.194.6.855","article-title":"Monocyte Selectivity and Tissue Localization Suggests a Role for Breast and Kidney-Expressed Chemokine (BRAK) in Macrophage Development","volume":"194","author":"Kurth","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/intimm\/12.5.677","article-title":"B Cell- and Monocyte-Activating Chemokine (BMAC), a Novel Non-ELR Alpha-Chemokine","volume":"12","author":"Sleeman","year":"2000","journal-title":"Int. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.174.9.5490","article-title":"Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), While Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both in Vitro and in Vivo","volume":"174","author":"Shurin","year":"2005","journal-title":"J. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ebiom.2017.09.012","article-title":"CXCL14 Acts as a Specific Carrier of CpG DNA into Dendritic Cells and Activates Toll-like Receptor 9-Mediated Adaptive Immunity","volume":"24","author":"Tanegashima","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.7150\/ijbs.79438","article-title":"CXCL14 Promotes Metastasis of Non-Small Cell Lung Cancer through ACKR2-Depended Signaling Pathway","volume":"19","author":"Chang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cas.15587","article-title":"Hypoxia-Induced CXC Chemokine Ligand 14 Expression Drives Protumorigenic Effects through Activation of Insulin-like Growth Factor-1 Receptor Signaling in Glioblastoma","volume":"114","author":"Wei","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1172\/JCI99974","article-title":"HIC1 Deletion Promotes Breast Cancer Progression by Activating Tumor Cell\/Fibroblast Crosstalk","volume":"128","author":"Wang","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/cvr\/cvaa080","article-title":"The Chemokine CXCL14 Mediates Platelet Function and Migration via Direct Interaction with CXCR4","volume":"117","author":"Witte","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1096\/fj.201700013R","article-title":"Epithelial Chemokine CXCL14 Synergizes with CXCL12 via Allosteric Modulation of CXCR4","volume":"31","author":"Collins","year":"2017","journal-title":"FASEB J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1080\/13813455.2020.1769677","article-title":"Effect of Chemokine CXCL14 on in Vitro Angiogenesis of Human Hepatocellular Carcinoma Cells","volume":"128","author":"Liu","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/79738","article-title":"A Transmembrane CXC Chemokine Is a Ligand for HIV-Coreceptor Bonzo","volume":"1","author":"Matloubian","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Koenen, A., Babendreyer, A., Schumacher, J., Pasqualon, T., Schwarz, N., Seifert, A., Deupi, X., Ludwig, A., and Dreymueller, D. (2017). The DRF Motif of CXCR6 as Chemokine Receptor Adaptation to Adhesion. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173486"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.4049\/jimmunol.172.10.6362","article-title":"The Transmembrane CXC-Chemokine Ligand 16 Is Induced by IFN-Gamma and TNF-Alpha and Shed by the Activity of the Disintegrin-like Metalloproteinase ADAM10","volume":"172","author":"Abel","year":"2004","journal-title":"J. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2353\/ajpath.2009.080960","article-title":"CXCL16 Is Expressed in Podocytes and Acts as a Scavenger Receptor for Oxidized Low-Density Lipoprotein","volume":"174","author":"Gutwein","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.V96.1.41.013k53_41_49","article-title":"Expression and Coreceptor Activity of STRL33\/Bonzo on Primary Peripheral Blood Lymphocytes","volume":"96","author":"Sharron","year":"2000","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4049\/jimmunol.181.1.81","article-title":"Critical Role for the Chemokine Receptor CXCR6 in Homeostasis and Activation of CD1d-Restricted NKT Cells","volume":"181","author":"Germanov","year":"2008","journal-title":"J. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.bbrc.2005.03.200","article-title":"CXCL16 Is a Novel Angiogenic Factor for Human Umbilical Vein Endothelial Cells","volume":"331","author":"Zhuge","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3892\/or.2015.4520","article-title":"CXCL16 Induces Angiogenesis in Autocrine Signaling Pathway Involving Hypoxia-Inducible Factor 1\u03b1 in Human Umbilical Vein Endothelial Cells","volume":"35","author":"Yu","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.exphem.2016.01.008","article-title":"Phenotypic, Genotypic, and Functional Characterization of Normal and Acute Myeloid Leukemia-Derived Marrow Endothelial Cells","volume":"44","author":"Pizzo","year":"2016","journal-title":"Exp. Hematol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.1401704","article-title":"Cutting Edge: GPR35\/CXCR8 Is the Receptor of the Mucosal Chemokine CXCL17","volume":"194","author":"Burkhardt","year":"2015","journal-title":"J. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.4049\/jimmunol.176.4.2069","article-title":"Cutting Edge: Novel Human Dendritic Cell- and Monocyte-Attracting Chemokine-like Protein Identified by Fold Recognition Methods","volume":"176","author":"Pisabarro","year":"2006","journal-title":"J. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1152\/ajpendo.00083.2012","article-title":"CXCL17, an Orphan Chemokine, Acts as a Novel Angiogenic and Anti-Inflammatory Factor","volume":"304","author":"Lee","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/abbs\/gmp051","article-title":"Overexpression of VCC-1 Gene in Human Hepatocellular Carcinoma Cells Promotes Cell Proliferation and Invasion","volume":"41","author":"Mu","year":"2009","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2017.09.113","article-title":"The Role and Clinical Significance of the CXCL17-CXCR8 (GPR35) Axis in Breast Cancer","volume":"493","author":"Guo","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic Acid as a Ligand for Orphan G Protein-Coupled Receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:50:37Z","timestamp":1760129437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":121,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["cancers15184555"],"URL":"https:\/\/doi.org\/10.3390\/cancers15184555","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]}}}